证券代码：001231 证券简称：农心科技 公告编号：2025-023 农心作物科技股份有限公司 第二届董事会第二十三次会议决议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"）第二届董事会第二十三次 会议（以下简称"本次会议"）经董事长召集，于 2025 年 4 月 13 日以电子邮件 方式发出会议通知，于 2025 年 4 月 24 日以现场结合视频会议方式召开并表决。 本次会议应到董事 9 名，实到董事 9 名，其中董事长郑敬敏先生及董事王小见先 生、郑杨柳女士、袁江先生、刘永孝先生、卫少安先生于会议现场参会并表决， 独立董事段又生先生、郭世辉先生、金春阳先生以视频会议方式参会并表决，公 司监事和高级管理人员列席本次会议。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》《农心作 物科技股份有限公司章程》《农心作物科技股份有限公司董事会议事规则》等有 关规定，各位董事确认对本次会议的召集、召开及表决方式无异议。与会董事对 本次会议的全部议案进行了充分审查，审慎表决，形成如下决议： 一、审议通过《 ...

本年度公司拟以 100,000,000 股为基数，向全体股东每 10 股派发现金红利 1.50 元（含税），本次利润分配不送红股，不以资本公积转增股本，剩余未分 配利润结转至以后年度。 证券代码：001231 证券简称：农心科技 公告编号：2025-026 农心作物科技股份有限公司 关于2024年度利润分配预案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日召开 第二届董事会第十次独立董事专门会议、第二届董事会第二十三次会议、第二届 监事会第二十一次会议，审议通过了《关于 2024 年度利润分配预案的议案》， 该预案尚需提交公司 2024 年年度股东大会审议。现将该预案的基本情况公告如 下： 一、2024 年度利润分配预案基本内容 经信永中和会计师事务所（特殊普通合伙）审计确认，公司 2024 年度合并 报表归属于母公司股东的净利润为 59,924,716.94 元，其中母公司实现的净利润 为人民币 47,158,441.83 元。根据《公司法》《企业会计准则》及《公司章程》 ...

Revenue and Profit - The company's revenue for Q1 2025 was CNY 207,671,491.74, representing a 38.96% increase compared to CNY 149,446,049.96 in the same period last year[4] - Net profit attributable to shareholders was CNY 18,383,925.70, up 20.83% from CNY 15,214,215.02 year-over-year[4] - Basic and diluted earnings per share increased to CNY 0.19, reflecting a growth of 26.67% from CNY 0.15[4] - The net profit for the current period was ¥16,842,838.19 after tax expenses of ¥4,439,766.13, compared to ¥14,172,341.35 in the previous period[17] - Net profit attributable to the parent company was 18,383,925.70, an increase from 15,214,215.02, representing a growth of approximately 20.5% year-over-year[18] - The total comprehensive income amounted to 16,841,498.09, compared to 14,172,341.35 in the previous period, indicating a growth of about 18.8%[18] Cash Flow - The net cash flow from operating activities was negative at CNY -73,380,128.97, a decline of 128.88% compared to CNY -32,060,203.94 in the previous year[4] - Cash flow from operating activities showed a net outflow of -73,380,128.97, worsening from -32,060,203.94 in the previous period[20] - Cash inflow from investment activities was 162,796,328.42, up from 80,147,897.09, marking an increase of approximately 103.5%[20] - Cash flow from financing activities generated a net inflow of 146,319,622.56, compared to a net outflow of -9,357,038.30 in the previous period[22] - The ending cash and cash equivalents balance was 195,178,705.45, down from 483,863,440.76, indicating a decrease of about 59.6%[22] - The company received cash from sales of goods and services totaling 70,667,579.19, compared to 79,385,147.40 in the previous period[20] - The company reported a decrease in cash outflows for purchasing goods and services, which totaled 90,731,970.62, compared to 71,435,060.57 previously[20] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 1,515,463,067.60, a 9.33% increase from CNY 1,386,078,522.05 at the end of the previous year[4] - The total assets as of March 31, 2025, were ¥1,515,463,067.60, up from ¥1,386,078,522.05 at the beginning of the period, representing a growth of about 9.3%[16] - The total liabilities increased to ¥529,082,219.01 from ¥417,110,750.02, marking an increase of approximately 27.0%[16] - The cash and cash equivalents at the end of the period were ¥261,933,705.45, compared to ¥234,614,462.78 at the beginning, showing an increase of about 11.6%[15] Operating Performance - The company experienced a 55.99% rise in operating costs, attributed to the sales of new pesticide products that were not in production during the same period last year[8] - The total operating costs amounted to ¥187,696,480.91, up from ¥132,751,960.20, reflecting a growth of about 41.4%[17] - The operating profit for the current period was ¥21,296,573.41, compared to ¥18,466,845.00 in the previous period, indicating an increase of approximately 9.9%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,569, with the largest shareholder holding 42.37% of the shares[10] - The company completed the initial grant of 1,195,000 restricted stocks under the 2025 incentive plan, involving 133 participants[12] Other Financial Metrics - The weighted average return on equity improved to 1.90%, up from 1.60% in the previous year[4] - The company received government subsidies amounting to CNY 148,229.63, which are closely related to its normal business operations[5] - The company reported a significant increase in accounts receivable by 96.93%, primarily due to uncollected sales from subsidiaries[8] - The company reported a decrease in inventory from ¥178,786,966.54 to ¥148,429,614.26, a reduction of approximately 17.0%[15]

Financial Performance - The company's operating revenue for 2024 was ¥649,266,065.11, representing a 7.19% increase compared to ¥605,703,563.29 in 2023 [18]. - The net profit attributable to shareholders for 2024 was ¥59,924,716.94, a 14.56% increase from ¥52,309,731.26 in 2023 [18]. - The basic earnings per share for 2024 was ¥0.60, up 15.38% from ¥0.52 in 2023 [18]. - Total assets at the end of 2024 were ¥1,386,078,522.05, a 2.41% increase from ¥1,353,476,384.29 at the end of 2023 [18]. - The gross profit margin for the chemical raw materials and chemical products manufacturing industry was 33.24%, an increase of 0.71% compared to the previous year [67]. - The company achieved a total operating revenue of ¥649,266,065.11, representing a year-on-year increase of 7.19% [62]. - The net profit attributable to shareholders was ¥59,924,716.94, up 14.56% compared to the previous year [62]. - The total sales revenue from domestic operations was ¥647,383,965.34, with a gross profit margin of 33.25% [67]. Dividend Distribution - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total of 100,000,000 shares [4]. - The company distributed a cash dividend of 0.8 yuan per 10 shares for the 2023 fiscal year, totaling 7,886,035.60 yuan [183]. - For the 2024 interim profit distribution, the company plans to distribute a cash dividend of 0.5 yuan per 10 shares, totaling 4,928,772.25 yuan [184]. - The total distributable profit for the parent company at the end of 2024 is 184,214,830.35 yuan, after accounting for dividends paid and statutory reserves [186]. Business Operations - The company operates in the pesticide manufacturing sector, classified under C263 of the chemical raw materials and chemical products manufacturing industry [4]. - The company has not reported any changes in its main business since its listing [15]. - The company has subsidiaries including Shaanxi Shangge Road Biological Science Co., Ltd. and Xinjiang Norsyn Crop Technology Co., Ltd. [9]. - The company has a registered address in Xi'an, Shaanxi Province, and has maintained this address since its listing [12]. - The company’s fiscal year runs from January 1 to December 31 [9]. - The company has a commitment to environmental and social responsibility, as outlined in its annual report [5]. Research and Development - The company has increased its R&D investment and personnel in recent years, aiming to improve product market share through continuous technological advancements [45]. - The number of R&D personnel increased to 65 in 2024, up 18.18% from 55 in 2023 [78]. - R&D investment amounted to ¥40,605,335.37 in 2024, reflecting a 2.42% increase from ¥39,644,193.81 in 2023 [79]. - The company is focusing on expanding its competitive advantages in pest control through innovative product formulations [77]. - The company is developing a more efficient and safer pesticide for cotton aphids, aiming to enhance market share in this segment [77]. Market Position and Strategy - The company ranked 27th in the pesticide formulation industry sales according to the 2024 Pesticide Industry Formulation Sales TOP100, indicating a strong market position [45]. - The company is actively pursuing international market expansion and technological collaboration to enhance its global competitiveness [44]. - The company is focusing on building a stable supply chain advantage by developing the first phase of its pesticide raw material production line [115]. - The company is exploring the use of novel active ingredients to enhance the efficacy of its pest control products [77]. - The company is considering strategic acquisitions to enhance its product portfolio, with potential targets identified in the technology sector [160]. Environmental and Regulatory Compliance - The company is responding to higher environmental requirements and opportunities for innovation in the pesticide sector due to government policies promoting green development [29]. - The implementation of new water pollution discharge standards for the pesticide industry is expected to strengthen environmental risk prevention and promote green transformation [32]. - The government is enhancing regulatory support for the pesticide industry, promoting green and sustainable development through stricter production licensing and environmental standards [39]. - Regulatory changes in the pesticide industry may increase operational challenges and costs, necessitating careful management of compliance risks [123]. Corporate Governance - The company has held five shareholder meetings during the reporting period, ensuring compliance with legal and regulatory requirements for governance [129]. - The board of directors consists of 9 members, including 3 independent directors, complying with legal requirements [131]. - The company maintained strict compliance with information disclosure regulations, ensuring accurate and timely reporting [137]. - The company has established a complete independent management system for procurement, production, sales, and R&D [142]. - The company’s audit committee supervises the internal audit system and reviews audit plans and reports [194]. Employee Management and Development - The total number of employees at the end of the reporting period is 699, with 168 in the parent company and 531 in major subsidiaries [177]. - The company has established a comprehensive training system, conducting over 100 training sessions during the reporting period to enhance employee skills and management capabilities [180]. - The company emphasizes a fair and reasonable compensation mechanism, aligning employee salaries with local average wage levels and company performance [179]. - The educational background of employees shows that 388 have an associate degree or below, 251 hold a bachelor's degree, 59 have a master's degree, and 1 has a doctoral degree [178]. Future Outlook - Future outlook indicates a projected revenue growth of 15% for the next fiscal year, driven by new product launches and market expansion strategies [157]. - The company plans to enhance its product development by increasing R&D investment to create more impactful products in the market [111]. - Market expansion plans include entering three new regional markets by Q3 2024, aiming to increase market share by 10% [159]. - The company is investing in R&D for new technologies, with a budget allocation of $10 million for the upcoming year [158].

作 者丨 易妍君 编 辑丨包芳鸣 黎雨桐 4月9日，A股港股、亚太股市集体低开。 截至发稿，上证指数跌超2%，深证成指跌超3%，创业板指跌超3%。 | 上证指数 | 深证成指 | 北证50 | | --- | --- | --- | | 3075.75 | 9138.12 | 1069.49 | | -69.80 -2.22% -286.56 -3.04% -24.90 -2.28% | | | | 科创50 | 创业板指 | 万得全A | | 920.49 | 1782.94 | 4514.46 | | -19.60 -2.09% -57.37 -3.12% | | -160.08 -3.42% | | 沪深300 | 中证500 | 中证A500 | | 3594.22 | 5141.90 | 4170.06 | | -56.54 -1.55% -185.02 -3.47% -89.25 -2.10% | | | | 中证1000 | 中证2000 | 中证红利 | | 5232.41 | 2027.20 | 5144.99 | | -297.60 -5.38% -155.92 -7.14% | | -1 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要内容提示： 1、首次授予日：2025 年 3 月 20 日 2、首次授予的限制性股票上市日：2025 年 4 月 8 日 证券代码：001231 证券简称：农心科技 公告编号：2025-021 农心作物科技股份有限公司 关于2025年限制性股票激励计划首次授予登记完成的公告 3、实际首次授予限制性股票的数量：119.50 万股，占首次授予日公司总股 本的 1.20% 4、首次授予价格：8.74 元/股 5、实际首次授予登记人数：133 人 6、股权激励方式：限制性股票 7、限制性股票来源：自二级市场回购的本公司人民币 A 股普通股股票 根据《上市公司股权激励管理办法》及深圳证券交易所、中国证券登记结 算有限责任公司深圳分公司的有关规定，农心作物科技股份有限公司（以下简 称"公司"或"本公司"）于2025年4月8日完成了2025年限制性股票激励计划 （以下简称"本次激励计划"）首次授予限制性股票的登记工作，现将有关事 项公告如下： 一、本次激励计划已履行的相关审批程序及信息披露情况 （一）2025 年 2 月 ...

证券代码： 001231 证券简称：农心科技 农心作物科技股份有限公司 投资者关系活动记录表 编号：2025-001 投资者关系活动 类别 □ 特定对象调研 □ 分析师会议 □ 媒体采访 □ 业绩说明会 □ 新闻发布会 □ 路演活动 ☑ 现场参观 ☑ 其他 （座谈会交流） 参与单位名称及 人员姓名 西部证券股份有限公司及资本市场自然人投资者共 24 人 时间 2025 年 3 月 26 日 (周三) 15:00~17:00 地点 陕西上格之路生物科学有限公司厂区、会议室 形式 现场参观、座谈会交流 上市公司接待人 员姓名 1、董事长、总经理 郑敬敏先生 2、董事会秘书、副总经理 袁江先生 3、证券事务代表 白喜富先生 投资者关系活动 主要内容 2025 年 3 月 26 日，西部证券股份有限公司（以下简称"西 部证券"）投资者代表及资本市场中关心、关注公司发展的投资 者共 24 人来访参观了本公司全资子公司陕西上格之路生物科学 有限公司（以下简称"上格之路"），并于参观后与公司管理层 座谈交流，本次活动有关情况如下： 公司董事长、董事会秘书及上格之路生产、研发主要负责人 向来访嘉宾现场讲解了上格之路制剂工厂的 ...

证券代码：001231 证券简称：农心科技 公告编号：2025-019 农心作物科技股份有限公司 第二届监事会第二十次会议决议的公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"）第二届监事会第二十次会 议（以下简称"本次会议"）由监事会主席召集，本次会议经监事会全体监事一 致同意豁免提前通知，于 2025 年 3 月 20 日以现场结合视频会议方式召开并表决。 本次会议应到监事 3 名，实到监事 3 名。 本次会议的召集、召开和表决程序符合《中华人民共和国公司法》《农心作 物科技股份有限公司章程》《农心作物科技股份有限公司监事会议事规则》以及 有关法律法规的规定，各位监事确认对本次会议的召集、召开及表决方式无异议。 与会监事对本次会议的全部议案进行了充分审查，审慎表决，形成如下决议： 一、审议通过《关于豁免本次会议提前通知的议案》 表决结果：通过。同意 3 票，反对 0 票，弃权 0 票，赞成票占董事会有效表 决票的 100%。 二、审议通过《关于向激励对象首次授予限制性股票的议案》 表决结果：通过。同意 3 票 ...

证券代码：001231 证券简称：农心科技 公告编号：2025-017 农心作物科技股份有限公司 本公司及全体独立董事保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 第二届董事会第九次独立董事专门会议决议的公告 农心作物科技股份有限公司（以下简称"公司"）第二届董事会第九次独立 董事专门会议经全体独立董事一致同意豁免提前通知，于 2025 年 3 月 20 日以现 场结合视频会议方式召开。 本次会议的召集、召开和表决程序符合《上市公司独立董事管理办法》《农 心作物科技股份有限公司章程》《农心作物科技股份有限公司独立董事专门会议 工作细则》等有关规定，各位独立董事确认对本次会议的召集、召开及表决方式 无异议。与会独立董事对本次会议的全部议案进行了充分审查，审慎表决，形成 如下决议： 备查文件： 《农心作物科技股份有限公司第二届董事会第九次独立董事专门会议决议》。 特此公告！ 农心作物科技股份有限公司 独立董事专门会议 一、审议通过《关于豁免本次会议提前通知的议案》 表决结果：通过。同意 3 票，反对 0 票，弃权 0 票，赞成票占董事会有效表 决票的 100%。 二、审议通过《关于向 ...

证券代码：001231 证券简称：农心科技 公告编号：2025-018 农心作物科技股份有限公司 第二届董事会第二十二次会议决议的公告 董事会意见： 根据《上市公司股权激励管理办法》、公司《2025 年限制性股票激励计划 （草案）》及其摘要等有关规定以及公司 2025 年第一次临时股东大会的授权， 董事会认为公司 2025 年限制性股票激励计划规定的首次授予条件已经成就，同 意以 2025 年 3 月 20 日为首次授予日，以 8.74 元/股的价格向符合首次授予条件 的 137 名激励对象授予 121.7000 万股限制性股票。 公司董事会薪酬与考核委员会已审议通过该议案，并出具了专项意见。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 农心作物科技股份有限公司（以下简称"公司"）第二届董事会第二十二次 会议（以下简称"本次会议"）由董事长召集，本次会议经董事会全体董事一致 同意豁免提前通知，于 2025 年 3 月 20 日以现场结合视频会议方式召开并表决。 本次会议应到董事 9 名，实到董事 9 名。 本次会议的召集、召开和表决程序符合《中华人民共和国 ...